KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells-Reference-Cited by-同舟云学术

KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells

Published:2019-05 Issue:5 Volume:26 Page:361-371
ISSN:1545-9993
Container-title:Nature Structural & Molecular Biology
language:en
Short-container-title:Nat Struct Mol Biol

Author:

Metzger Eric,Wang Sheng,Urban Sylvia,Willmann Dominica,Schmidt Andreas,Offermann Anne,Allen Anita,Sum Manuela,Obier Nadine,Cottard Félicie,Ulferts Svenja,Preca Bogdan-Tiberius,Hermann Bianca,Maurer Jochen^ORCID,Greschik Holger,Hornung Veit,Einsle Oliver,Perner Sven,Imhof Axel^ORCID,Jung Manfred^ORCID,Schüle Roland^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Structural Biology

Link

http://www.nature.com/articles/s41594-019-0219-9.pdf

Reference46 articles.

1. Strahl, B. D. & Allis, C. D. The language of covalent histone modifications. Nature 403, 41–45 (2000).

2. Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K. & Schapira, M. Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug Discov. 11, 384–400 (2012).

3. Dillon, S. C., Zhang, X., Trievel, R. C. & Cheng, X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 6, 227 (2005).

4. van Leeuwen, F., Gafken, P. R. & Gottschling, D. E. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109, 745–756 (2002).

5. Petrossian, T. C. & Clarke, S. G. Uncovering the human methyltransferasome. Mol. Cell Proteomics 10, M110 000976 (2011).

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reversal of endocrine resistance via N6AMT1-NEDD4L pathway-mediated p110α degradation;2024-08-17

2. HemK2 functions for sufficient protein synthesis and RNA stability through eRF1 methylation during Drosophila oogenesis;Development;2024-07-15

3. Cytosolic N6AMT1-dependent translation supports mitochondrial RNA processing;2024-07-02

4. Cross-Reactivity of N6AMT1 Antibodies with Aurora Kinase A: An Example of Antibody-Specific Non-Specificity;Antibodies;2024-04-22

5. Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer;Cancers;2024-04-17